甘李药业(603087.SH)：旭特宏达累计减持0.57%股份

Group 1 - The core point of the article is that Ganli Pharmaceutical (603087.SH) announced the completion of a share reduction plan by Xutong Hongda, which involved a total reduction of 3.3995 million shares, accounting for 0.57% of the company's total share capital [1]